4//SEC Filing
INNOVUS PHARMACEUTICALS, INC. 4
Accession 0001415889-16-007481
CIK 0001411879operating
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:00 AM ET
Size
8.1 KB
Accession
0001415889-16-007481
Insider Transaction Report
Form 4
ESBER HENRY JEMIL
Director
Transactions
- Award
Restricted Stock Units
2016-11-16$0.25/sh+416,667$104,167→ 1,215,208 totalFrom: 2016-11-16Exp: 2026-11-16→ Common Stock (416,667 underlying) - Award
Restricted Stock Units
2016-10-01$0.26/sh+23,076$6,000→ 798,541 totalFrom: 2016-10-01Exp: 2026-10-01→ Common Stock (23,076 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F2]The reporting person was granted a Restricted Stock unit on October 1, 2016 of 23,076 shares, which was fully vested on the date of grant.
- [F3]These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan.
- [F4]The Reporting Person was granted a Restricted Stock Unit on November 16, 2016 of 416,667 shares, which was fully vested on the date of the grant.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411879
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:00 AM ET
- Size
- 8.1 KB